Study Reference No. - 20-385

Study Type Demographic Gender Age Location Compensation
Investigational Oral Drug Study Healthy volunteers Males and Females 18 - 45 years old Saint Petersburg FL $1,500.00
Study Details

Study Objective

The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S. Food and Drug Administration (FDA)] capsule is bioequivalent (to see if the active test study drug is absorbed into the body at the same rate and amount as an already approved drug)] to a currently marketed tablet, as well as to monitor the safety of the study subjects.

Study Duration

4 Visits

Study Schedule

General Screening


Medical Screening

Jan 13th - 22nd

Study Visit(s)

Group 1 - Period 1: Mon Jan 25th - Wed 27th

Group 1 - Period 2: Fri Jan 29th - Sun 31st

Group 1 - Period 3: Tue Feb 2nd - Thu 4th

Group 2 - Period 1: Wed Jan 27th - Fri 29th

Group 2 - Period 2: Sun Jan 31th - Thu Feb 2th

Group 2 - Period 3: Thu Feb 4th - Sat 6th

Other Notes

This study requires overnight stays